Skip to content

A Brief Mind-Body Bridging Intervention for Suicidal Ideation

A Randomized Pilot Study of a Brief Mind-Body Bridging Intervention for Suicidal Ideation

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03677882
Enrollment
13
Registered
2018-09-19
Start date
2018-12-18
Completion date
2023-01-31
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mind Body Bridging, Suicidal Ideation

Keywords

mind body bridging, mindfulness, suicidal ideation, suicide related behaviors

Brief summary

The aim of this study is to determine whether a Brief Mind-Body Bridging Intervention for Suicidal Ideation (MBB-SI) will result in short or longer-term reduction of psychological factors associated with suicidal ideation (SI) and/or suicide-related behaviors (SRB's) compared to Treatment as Usual (TAU).

Interventions

BEHAVIORALMind Body Bridging Group Session

Participants assigned to TAU + MBB will will receive treatment from the Suicide Prevention Team and the Mental Health Service, AND will be asked to participate in consisting of three to eight 60-minute sessions that will occur consecutively. Each group will be led by a trained MBB facilitator. Participants will receive a workbook at the beginning of the training that contains an explanation of all the major concepts involved in Mind Body Bridging. The workbook has homework assignments to be completed daily between group sessions.

Sponsors

Mind Body Bridging Charity
CollaboratorUNKNOWN
VA Salt Lake City Health Care System
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Subjects will be Veterans aged 18-80 admitted to Substance Abuse Residential Rehabilitation Treatment Program (SARRTP) with addictive disorders and/or co-occurring psychiatric disorder with suicide risk factors.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Change in frequency and/or intensity of suicidal ideationWeekly during the intervention, one-month post-intervention, three months post-intervention, six months post-interventionDetermine if there is a significant difference in the frequency and/or intensity of suicidal ideation, as measured by the Beck Scale for Suicide Ideation (BSS) among the MBB-SI + TAU cohort compared to the TAU. We will use the total BSS score, ranging from 0 to 38. Increased scores reflect greater suicide risk.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026